Bruker (NASDAQ: BRKR ) has closed the acquisition of ZONTAL, an innovative platform provider for the digital transformation of the analytical laboratory, and for integrated biopharma technical data solutions. This acquisition further strengthens Bruker BioSpin’s Integrated Data Solutions software division, which includes Mestrelab Research, Arxspan, and Optimal. Financial terms of the acquisition were not disclosed, and ZONTAL expects 2023 revenues of greater than $5M. The acquisition will enable integrated digital laboratory and process data management, combining vendor-agnostic data storage and analysis, as well as workflow tools to help scientists realize the full potential of their analytical laboratory and process digital assets.
K&X Design and Investment Technology, LLC
Invest The Invisible Impact
K&X Design and Investment Technology, LLC
Invest The Invisible Impact
